Seahorse XF technology helps to determine a new therapeutic approach for treating acute myeloid leukemia (AML)
You Might Also Like
Oxford Nanopore sequencing technology used to develop an assay for comprehensive variant analysis in spinal muscular atrophy (SMA)
Agilent and BioTek Join Forces to Create an Integrated Metabolic Analysis and Imaging Platform
